SECURITIES LENDING TOP 10 EARNING EQUITIES - MARCH 09, 2015


Methodology: We scan our universe of more than 42,000 securities on loan to find those securities with the most expensive financing positions in the U.S., U.K., Europe and Asia. Financing costs are determined by taking the total on-loan value of a security and multiplying it by the volume-weighted average fees to borrow that security, then converting the product of those numbers to a dollar value. We then sort the most expensive securities to finance in the securities lending market in descending order.

US

Utilization

1     GAMESTOP CL A 89.89%
2     TRANSOCEAN 87.85%
3     ULTRA PETROLEUM 85.70%
4     AMBARELLA 94.98%
5     MANNKIND 95.97%
6     3D SYSTEMS 97.96%
7     NOW 98.40%
8     MYRIAD GENETICS 92.62%
9     INVENSENSE 81.16%
10   DIAMOND OFFSHORE DRILLING 82.61%


UK

Utilization

1     TALKTALK TELECOM GROUP 87.40%
2     ASOS 73.11%
3     ASHMORE GROUP 88.14%
4     QUINDELL 93.22%
5     LONMIN 92.71%
6     JSC VTB BANK GDR 24.75%
7     SAINSBURYJ 69.68%
8     BP

3.91%

9     STANDARD CHARTERED 18.55%
10   MONITISE 47.64%


Europe

Utilization

1     TRANSOCEAN (CH) 96.94%
2     GEMALTO (NL) 90.53%
3     GTECH (IT) 89.96%
4     SUEDZUCKER MANNHEIM OCHSENFURT (DE) 82.26%
5     TALKTALK TELECOM GROUP 87.40%
6     TOTAL (FR) 11.15%
7     GEMALTO (FR) 74.04%
8     AIR FRANCE-KLM (FR) 95.05%
9     TGS NOPEC GEOPHYSICAL (NO) 71.47%
10   MEYER BURGER TECHNOLOGY (CH) 95.05%


Far East/Australia Pacific

Utilization

1     HANERGY TFP (HK) 94.37%
2     CELLTRION (KR) 79.13%
3     EVERGRANDE (HK) 89.00%
4     DAUM KAKAO (KR) 80.01%
5     SANRIO (JP) 91.68%
6     GUNGHO ONLINE (JP) 81.78%
7     PRADA (HK) 76.69%
8     MIXI (JP) 77.71%
9     GREE (JP) 64.54%
10   CSR H (HK) 91.16%


This is just a snapshot of the rich data and functionalities provided by DataLend. Click here for more information about DataLend's key features.



THE INFORMATION CONTAINED HEREIN IS PROPRIETARY TO EQUILEND; MAY NOT BE COPIED OR DISTRIBUTED WITHOUT THE EXPRESS CONSENT OF EQUILEND; SHALL NOT CONSTITUTE INVESTMENT ADVICE BY EQUILEND, OR ANY REPRESENTATIVE THEREOF; IS NOT WARRANTED TO BE ACCURATE, COMPLETE OR TIMELY; IS PROVIDED FOR INFORMATIONAL PURPOSES ONLY; IS NOT INTENDED FOR TRADING PURPOSES; AND SHOULD NOT BE CONSTRUED AS EQUILEND MAKING FORECASTS, PROJECTING RETURNS OR RECOMMENDING ANY PARTICULAR COURSE OF ACTION. NEITHER EQUILEND NOR ANY REPRESENTATIVE THEREOF SHALL BE AN ADVISOR OR A FIDUCIARY OF A VISITOR TO THIS WEBSITE. EQUILEND IS NOT RESPONSIBLE OR LIABLE IN ANY WAY TO THE READER OR VISITOR, OR TO ANY PERSON, FIRM OR CORPORATION FOR ANY DAMAGES OR LOSSES ARISING FROM ANY USE OF THE INFORMATION CONTAINED HEREIN. IN CONSIDERING THE INFORMATION CONTAINED HEREIN, A VISITOR TO THIS WEBSITE DOES SO SOLELY IN RELIANCE ON THE VISITOR’S OWN JUDGMENT. PAST PERFORMANCE IS NO GUARANTEE OF FUTURE PERFORMANCE.

DATALEND ALERTS

Sign up for weekly DataLend Top 10 email alerts



DATA ARCHIVE

March 09, 2015

March 2, 2015

February 27, 2015

January 26, 2015

November 19, 2014

November 12, 2014

November 5, 2014

October 22, 2014

October 15, 2014

October 8, 2014

September 19, 2014

September 5, 2014

August 28, 2014

August 21, 2014

July 24, 2014

June 26, 2014

June 19, 2014

June 12, 2014

June 5, 2014

May 29, 2014

May 22, 2014

May 16, 2014

May 8, 2014

May 1, 2014

April 25, 2014

April 11, 2014

April 4, 2014

March 20, 2014

March 13, 2014

March 7, 2014

February 27, 2014

February 20, 2014

February 7, 2014